StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > ⚡⚡⚡NEWS - COMPETITION⚡⚡⚡

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Feb 21, 2021 8:53pm

147 Views

Post# 32623406

RE:⚡⚡⚡NEWS - COMPETITION⚡⚡⚡

Grail worth billions has a 39% detection rate on stage 1. Won't be out until 2025.

"The overall detection rate for the substudy for all cancer types was 43.9% across stages I, II and III. Those stages are marked by localized disease that hasn’t spread throughout the body."

Let me say that again worth billions and less than 40% accurate. Stagezero is so undervalued !!